Table 2.
Pre-operative diagnoses stratified by extent of hepato-pancreatectomy
| <Hemi-hepatectomy + Distal (n = 224) | ≥Hemi-hepatectomy + Distal (n = 49) | <Hemi-hepatectomy + PD (n = 183) | ≥Hemi-hepatectomy + PD (n = 24) | Total (%) | |
|---|---|---|---|---|---|
| Pancreatic malignancy | 52 (23.2) | 11 (22.4) | 83 (45.4) | 4 (16.7) | 150 (31) |
| Neuroendocrine tumour | 54 (24.2) | 15 (30.6) | 19 (10.4) | 5 (20.8) | 93 (19.3) |
| Secondary liver malignancy | 40 (17.9) | 11 (22.4) | 13 (7.1) | 0 (0) | 64 (13.3) |
| Benign pancreatic disease | 19 (8.5) | 0 (0) | 5 (2.7) | 0 (0) | 24 (5) |
| Bile duct malignancy | 2 (0.9) | 2 (4.1) | 7 (3.8) | 10 (41.7) | 21 (4.4) |
| Gastric malignancy | 17 (7.6) | 1 (2.0) | 1 (0.5) | 0 (0) | 19 (4) |
| Gallbladder malignancy | 0 (0) | 1 (2.0) | 14 (7.7) | 1 (4.2) | 16 (3.3) |
| Colorectal malignancy | 6 (2.7) | 0 (0) | 7 (3.8) | 1 (4.2) | 14 (2.9) |
| Ampullary malignancy | 0 (0) | 0 (0) | 11 (6.0) | 0 (0) | 11 (2.3) |
| Duodenal malignancy | 2 (0.9) | 0 (0) | 6 (3.3) | 2 (8.3) | 10 (2.1) |
| Primary liver malignancy | 4 (1.8) | 2 (4.1) | 3 (1.6) | 1 (4.2) | 10 (2.1) |
| Retroperitoneal tumour | 8 (3.6) | 0 (0) | 4 (2.2) | 0 (0) | 12 (1.5) |
| Benign biliary disease | 4 (1.8) | 1 (2.0) | 1 (0.5) | 0 (0) | 6 (1.3) |
| Adrenal malignancy | 1 (0.4) | 0 (0) | 0 (0) | 0 (0) | 1 (0.2) |
| Ovarian malignancy | 1 (0.4) | 0 (0) | 0 (0) | 0 (0) | 1 (0.2) |
| Other | 14 (6.3) | 5 (10.2) | 9 (4.9) | 0 (0) | 28 (5.8) |
| Total | 224 | 49 | 183 | 24 | 480 |